BMAR Performance — Innovator U.S. Equity Buffer ETF - March
Data updated: 2026-09-28
BMAR returned +9.20% year to date and +16.22% over one year to Jul 2026. Annualised returns are +15.30% over 3 years and +11.81% over 5 years. Against its US Blend category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $153, against $147 for the category, and to $116 over one year, against $120. Volatility over the past three years was 8.74% a year. In the 12 months to Jul 2026 the fund lost a net $684K, and assets reached $250.60M.
BMAR Growth of $100
What $100 invested in Innovator U.S. Equity Buffer ETF - March grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Blend category average over the same months.
| Period | BMAR | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $116 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $153 | $147 |
| 5 years (Aug 2021 – Jul 2026) | $175 | $143 |
| Since data start (Feb 2020 – Jul 2026) | $223 | $169 |
BMAR Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +9.20% |
| 1 year | +16.22% |
| 3 years (annualised) | +15.30% |
| 5 years (annualised) | +11.81% |
BMAR Annual Returns
Calendar-year total returns of Innovator U.S. Equity Buffer ETF - March, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +9.20% |
| 2025 | +14.86% |
| 2024 | +16.46% |
| 2023 | +23.22% |
| 2022 | −6.96% |
| 2021 | +16.47% |
| 2020 (Feb–Dec) | +14.20% |
BMAR Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +1.1% | +1.1% | −3.4% | +7.1% | +2.8% | −0.1% | +0.6% | — | — | — | — | — |
| 2025 | +2.0% | +0.4% | −3.8% | −0.6% | +4.6% | +3.5% | +1.7% | +1.5% | +2.0% | +1.0% | +0.8% | +0.9% |
| 2024 | +1.4% | +1.3% | +2.1% | −2.5% | +3.9% | +2.5% | +0.8% | +2.0% | +1.5% | −0.4% | +3.7% | −0.8% |
| 2023 | +4.3% | +0.7% | +2.5% | +1.7% | +0.5% | +4.7% | +1.9% | −0.5% | −3.4% | −1.7% | +7.6% | +3.1% |
| 2022 | −0.6% | −0.7% | +2.1% | −5.9% | +0.4% | −5.9% | +6.6% | −2.8% | −5.8% | +5.5% | +3.7% | −2.8% |
| 2021 | −0.1% | +1.1% | +3.6% | +3.2% | +0.9% | +1.5% | +1.0% | +1.3% | −1.8% | +3.2% | −0.8% | +2.4% |
| 2020 | — | 0.0% | −9.8% | +9.8% | +3.7% | +0.5% | +3.4% | +2.5% | −1.1% | −0.8% | +5.3% | +1.1% |
BMAR Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 8.74%
- 3-year Sharpe ratio: 1.24 (vs 4.5% risk-free rate)
- Best month: +7.60% (Nov 2023)
- Worst month: −3.82% (Mar 2025)
BMAR Fund Flows
Monthly money in and out of Innovator U.S. Equity Buffer ETF - March, from SEC Form N-PORT.
- 12-month net flow: −$684K
- 12-month gross sales (incl. reinvestments): $71.8M
- Sales ÷ redemptions: 0.99×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $0 | $0 |
| Jun 2026 | $4.3M | $0 | $4.3M |
| May 2026 | $11.5M | $0 | $11.5M |
| Apr 2026 | $36.1M | $0 | $36.1M |
| Mar 2026 | $14.6M | $12.0M | $2.6M |
| Feb 2026 | $5.4M | $2.7M | $2.7M |
| Jan 2026 | $0 | $0 | $0 |
| Dec 2025 | $0 | $2.6M | −$2.6M |
| Nov 2025 | $0 | $3.8M | −$3.8M |
| Oct 2025 | $0 | $2.6M | −$2.6M |
| Sep 2025 | $0 | $48.8M | −$48.8M |
| Aug 2025 | $0 | $0 | $0 |
BMAR Assets Under Management
Net assets of Innovator U.S. Equity Buffer ETF - March by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $250.60M |
| 2026-04-30 | $227.35M |
| 2026-01-31 | $177.07M |
| 2025-10-31 | $178.69M |
| 2025-07-31 | $220.56M |
| 2025-04-30 | $182.05M |
| 2025-01-31 | $171.98M |
| 2024-10-31 | $177.32M |
| 2024-07-31 | $190.48M |
| 2024-04-30 | $182.42M |
| 2024-01-31 | $93.45M |
| 2023-10-31 | $87.54M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.